We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Chiesi Group

News List

Inhibrx Announces Agreement for INBRX-101 outside US, Canada with Chiesi Group americanpharmaceuticalreview
May 31, 2019
Inhibrx has entered into an agreement with Chiesi Farmaceutici. The agreement grants Chiesi Group an option to exclusively license, develop and commercialize INBRX-101 outside of ...
Chiesi Group has presented data at two international congresses on the role of its extrafine formulation ICS/LABA/LAMA vs LABA/LAMA in the treatment of COPD patients firstwordpharma
May 30, 2018
Chiesi Group (Chiesi), an international research-focussed healthcare company, was present at the American Thoracic Society (ATS) meeting in San Diego (18-23 May 2018) and at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Ann